Literature DB >> 20211723

An avian model for the reversal of neurobehavioral teratogenicity with neural stem cells.

Sharon Dotan1, Adi Pinkas, Theodore A Slotkin, Joseph Yanai.   

Abstract

A fast and simple model which uses lower animals on the evolutionary scale is beneficial for developing procedures for the reversal of neurobehavioral teratogenicity with neural stem cells. Here, we established a procedure for the derivation of chick neural stem cells, establishing embryonic day (E) 10 as optimal for progression to neuronal phenotypes. Cells were obtained from the embryonic cerebral hemispheres and incubated for 5-7 days in enriched medium containing epidermal growth factor (EGF) and basic fibroblast growth factor (FGF2) according to a procedure originally developed for mice. A small percentage of the cells survived, proliferated and formed nestin-positive neurospheres. After removal of the growth factors to allow differentiation (5 days), 74% of the cells differentiated into all major lineages of the nervous system, including neurons (Beta III tubulin-positive, 54% of the total number of differentiated cells), astrocytes (GFAP-positive, 26%), and oligodendrocytes (O4-positive, 20%). These findings demonstrate that the cells were indeed neural stem cells. Next, the cells were transplanted in two allograft chick models; (1) direct cerebral transplantation to 24-h-old chicks, followed by post-transplantation cell tracking at 24 h, 6 days and 14 days, and (2) intravenous transplantation to chick embryos on E13, followed by cell tracking on E19. With both methods, transplanted cells were found in the brain. The chick embryo provides a convenient, precisely-timed and unlimited supply of neural progenitors for therapy by transplantation, as well as constituting a fast and simple model in which to evaluate the ability of neural stem cell transplantation to repair neural damage, steps that are critical for progress toward therapeutic applications. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211723      PMCID: PMC2875338          DOI: 10.1016/j.ntt.2010.02.003

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  54 in total

Review 1.  Nestin structure and predicted function in cellular cytoskeletal organisation.

Authors:  K Michalczyk; M Ziman
Journal:  Histol Histopathol       Date:  2005-04       Impact factor: 2.303

2.  A role for stem cell biology in the physiological and pathological aspects of aging.

Authors:  Evan Y Snyder; Jeanne F Loring
Journal:  J Am Geriatr Soc       Date:  2005-09       Impact factor: 5.562

Review 3.  Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma.

Authors:  I Kulbatski; A J Mothe; H Nomura; C H Tator
Journal:  Curr Drug Targets       Date:  2005-02       Impact factor: 3.465

4.  Learning-related fos-like immunoreactivity in the chick brain: time-course and co-localization with GABA and parvalbumin.

Authors:  R Ambalavanar; B J McCabe; K N Potter; G Horn
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism.

Authors:  Stefano Pluchino; Lucia Zanotti; Barbara Rossi; Elena Brambilla; Linda Ottoboni; Giuliana Salani; Marianna Martinello; Alessandro Cattalini; Alessandra Bergami; Roberto Furlan; Giancarlo Comi; Gabriela Constantin; Gianvito Martino
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

Review 6.  Adult stem cell therapy in stroke.

Authors:  Sebastian Haas; Norbert Weidner; Jürgen Winkler
Journal:  Curr Opin Neurol       Date:  2005-02       Impact factor: 5.710

7.  Advantages of having a lateralized brain.

Authors:  Lesley J Rogers; Paolo Zucca; Giorgio Vallortigara
Journal:  Proc Biol Sci       Date:  2004-12-07       Impact factor: 5.349

8.  Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis.

Authors:  N Shahani; A Nalini; M Gourie-Devi; T R Raju
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

9.  Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury.

Authors:  Andrea Kleindienst; Melissa J McGinn; Harlan B Harvey; Raymond J Colello; Robert J Hamm; M Ross Bullock
Journal:  J Neurotrauma       Date:  2005-06       Impact factor: 5.269

Review 10.  Review of epidermal growth factor receptor biology.

Authors:  Roy S Herbst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004       Impact factor: 7.038

View more
  3 in total

1.  Diverse neurotoxicants target the differentiation of embryonic neural stem cells into neuronal and glial phenotypes.

Authors:  Theodore A Slotkin; Samantha Skavicus; Jennifer Card; Edward D Levin; Frederic J Seidler
Journal:  Toxicology       Date:  2016-11-02       Impact factor: 4.221

2.  Establishment of a survival and toxic cellular model for Parkinson's disease from chicken mesencephalon.

Authors:  Amparo Tolosa; Xiaolai Zhou; Björn Spittau; Kerstin Krieglstein
Journal:  Neurotox Res       Date:  2012-12-13       Impact factor: 3.911

3.  Differentiation of human breast-milk stem cells to neural stem cells and neurons.

Authors:  Seyed Mojtaba Hosseini; Tahere Talaei-Khozani; Mahsa Sani; Bahareh Owrangi
Journal:  Neurol Res Int       Date:  2014-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.